Actively Recruiting
Continuous Versus Intermittent cARdiac Electrical moNitorinG
Led by Washington University School of Medicine · Updated on 2025-12-30
60
Participants Needed
1
Research Sites
162 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to validate the continuous patch monitoring system to evaluate cardiac arrhythmias in patients receiving drugs that can cause cardiac complications and compare the continuous patch system with standard electrocardiograms (ECGs).
CONDITIONS
Official Title
Continuous Versus Intermittent cARdiac Electrical moNitorinG
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of acute promyelocytic leukemia (APL) and starting standard arsenic trioxide treatment OR diagnosis of solid tumor and starting standard capecitabine or ribociclib treatment (alone or combined)
- At least 18 years old
- No allergy to adhesive patches
- Able to understand and willing to sign informed consent
You will not qualify if you...
- Younger than 18 years old
- Allergy to adhesive patches
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110
Actively Recruiting
Research Team
J
Joshua D Mitchell, M.D., FACC
CONTACT
K
Kaitlin Moore
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here